当前位置:首页 - 行情中心 - 仙琚制药(002332) - 财务分析 - 现金流量表

仙琚制药

(002332)

  

流通市值:86.55亿  总市值:86.85亿
流通股本:9.86亿   总股本:9.89亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,554,894,728.331,722,669,322.12710,971,908.643,516,488,366.64
  收到的税费返还177,665.88168,388.71129,640.987,030,355.86
  收到其他与经营活动有关的现金252,421,493.11143,953,203.01122,175,205.79142,586,780.82
  经营活动现金流入小计2,807,493,887.321,866,790,913.84833,276,755.413,666,105,503.32
  购买商品、接受劳务支付的现金465,331,423.51353,895,196.46152,250,012.46889,028,266.22
  支付给职工以及为职工支付的现金575,742,955.52413,973,233.69205,313,693.3738,685,264.13
  支付的各项税费259,693,495.38180,731,731.2177,458,262.44300,993,356.71
  支付其他与经营活动有关的现金892,169,833.42558,375,800.38263,469,975.571,489,920,611.49
  经营活动现金流出小计2,192,937,707.831,506,975,961.74698,491,943.773,418,627,498.55
  经营活动产生的现金流量净额614,556,179.49359,814,952.1134,784,811.64247,478,004.77
二、投资活动产生的现金流量:
  取得投资收益收到的现金3,852,112.763,852,112.761,000,0002,205,000
  处置固定资产、无形资产和其他长期资产收回的现金净额4,887,808.271,033,136.78909,552.58764,980.22
  处置子公司及其他营业单位收到的现金净额---10,462,250.55
  收到的其他与投资活动有关的现金---0
  投资活动现金流入小计8,739,921.034,885,249.541,909,552.5813,432,230.77
  购建固定资产、无形资产和其他长期资产支付的现金117,157,376.8483,187,908.0543,267,901.7209,073,996.22
  投资支付的现金5,700,000300,000300,000500,000
  支付其他与投资活动有关的现金---0
  投资活动现金流出小计122,857,376.8483,487,908.0543,567,901.7209,573,996.22
  投资活动产生的现金流量净额-114,117,455.81-78,602,658.51-41,658,349.12-196,141,765.45
三、筹资活动产生的现金流量:
  吸收投资收到的现金---1,350,000
  其中:子公司吸收少数股东投资收到的现金---1,350,000
  取得借款收到的现金289,500,000167,500,000100,000,000414,945,752
  筹资活动现金流入小计289,500,000167,500,000100,000,000416,295,752
  偿还债务支付的现金230,133,200.02205,274,641.76148,402,749.04270,941,299.26
  分配股利、利润或偿付利息支付的现金341,119,344.05201,550,024.29696,904.45401,510,861.48
  其中:子公司支付给少数股东的股利、利润2,400,0002,400,000--
  支付其他与筹资活动有关的现金152,814,493.8736,242,798.63855,127.285,053,918.68
  筹资活动现金流出小计724,067,037.94443,067,464.68149,954,780.77677,506,079.42
  筹资活动产生的现金流量净额-434,567,037.94-275,567,464.68-49,954,780.77-261,210,327.42
四、汇率变动对现金及现金等价物的影响-52,165,179.77-32,098,902.51-20,621,336.9225,614,564.1
五、现金及现金等价物净增加额13,706,505.97-26,454,073.622,550,344.83-184,259,524
  加:期初现金及现金等价物余额1,191,214,116.751,191,214,116.751,191,214,116.751,376,132,147.75
  期末现金及现金等价物余额1,204,920,622.721,164,760,043.151,213,764,461.581,191,872,623.75
补充资料:
  净利润-244,585,180.06-452,603,660.56
  资产减值准备-37,569,127.42-45,502,910.2
  固定资产和投资性房地产折旧-103,371,798.82-197,370,878.44
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-103,371,798.82-197,370,878.44
  无形资产摊销-10,248,025.5-20,483,525.48
  长期待摊费用摊销-2,785,229.8-2,789,649.96
  处置固定资产、无形资产和其他长期资产的损失-107,128.87--46,299,441.47
  固定资产报废损失-1,128,678.99-1,485,898.98
  财务费用-10,914,737.31-7,625,804.22
  投资损失-9,038,915.04-26,411,420.79
  递延所得税--3,115,294.39--4,704,151.87
  其中:递延所得税资产减少--3,115,294.39--4,704,151.87
  存货的减少--16,926,845.36--6,400,995.02
  经营性应收项目的减少--17,085,921.09--275,983,458.27
  经营性应付项目的增加--24,554,500.95--178,117,120.96
  现金的期末余额-1,164,760,043.15-1,191,872,623.75
  减:现金的期初余额-1,191,214,116.75-1,376,132,147.75
  现金及现金等价物的净增加额--26,454,073.6--184,259,524
公告日期2026-10-262026-08-282026-04-282026-04-23
审计意见(境内)标准无保留意见
TOP↑